US Stock MarketDetailed Quotes

Purple Biotech (PPBT)

Watchlist
  • 1.580
  • +0.040+2.60%
Close Jun 12 16:00 ET
  • 1.550
  • -0.030-1.90%
Post 20:01 ET
1.82MMarket Cap-0.03P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Purple Biotech (PPBT) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-57.79%-3.12M
60.63%-5.66M
47.02%-1.07M
67.62%-1.07M
61.17%-1.54M
61.08%-1.98M
27.89%-14.37M
59.57%-2.01M
9.87%-3.3M
23.88%-3.98M
Net income from continuing operations
80.48%-89K
-263.95%-26.49M
-5,596.87%-23.64M
-95.36%-1.31M
54.91%-1.09M
87.94%-456K
63.56%-7.28M
91.46%-415K
86.79%-668K
53.20%-2.42M
Depreciation and amortization
44.44%65K
9.14%203K
32.50%53K
18.37%58K
-4.08%47K
-6.25%45K
-5.58%186K
-16.67%40K
-2.00%49K
-7.55%49K
Other non cash items
-127.58%-2.16M
74.07%-966K
132.78%197K
95.43%-67K
85.03%-146K
-38.69%-950K
-62.42%-3.73M
57.32%-601K
-111.71%-1.47M
-4,000.00%-975K
Change In working capital
-44.79%-1.03M
118.65%808K
287.85%1.89M
103.50%47K
60.66%-415K
23.66%-710K
-1,681.02%-4.33M
-195.08%-1M
-184.36%-1.34M
-66.40%-1.06M
-Change in payables and accrued expense
-104.98%-947K
114.79%655K
242.42%1.6M
98.38%-24K
58.68%-457K
35.56%-462K
-1,816.28%-4.43M
-202.19%-1.12M
-218.17%-1.48M
-30.89%-1.11M
-Change in other current assets
67.34%-81K
59.38%153K
144.07%288K
-49.29%71K
-17.65%42K
-16.43%-248K
-46.07%96K
387.80%118K
-58.46%140K
-75.83%51K
Cash from discontinued investing activities
Operating cash flow
-57.79%-3.12M
60.63%-5.66M
47.02%-1.07M
67.62%-1.07M
61.17%-1.54M
61.08%-1.98M
27.89%-14.37M
59.57%-2.01M
9.87%-3.3M
23.88%-3.98M
Investing cash flow
Cash flow from continuing investing activities
-80.93%49K
24.17%632K
-373.68%-104K
416.67%372K
22.99%107K
-17.63%257K
-96.33%509K
-48.65%38K
-92.84%72K
-56.06%87K
Net PPE purchase and sale
----
---3K
---9K
--8K
----
----
--0
--0
--0
--0
Net intangibles purchase and sale
----
----
----
----
----
----
--0
----
----
----
Net business purchase and sale
----
--0
----
----
----
----
--0
--0
--0
--0
Net investment purchase and sale
-99.10%2K
137.57%449K
---147K
10,600.00%315K
1,100.00%60K
18.18%221K
-98.87%189K
--0
-100.34%-3K
66.67%5K
Net other investing changes
---4K
----
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-82.49%45K
24.17%632K
-373.68%-104K
416.67%372K
22.99%107K
-17.63%257K
-96.33%509K
-48.65%38K
-92.84%72K
-56.06%87K
Financing cash flow
Cash flow from continuing financing activities
-162.14%-64K
-6.51%6.33M
-120.23%-797K
212.14%6.66M
-15.47%366K
-61.57%103K
24.32%6.77M
-7.23%3.94M
273.08%2.13M
17.98%433K
Net issuance payments of debt
-11.32%-59K
-18.58%-217K
-27.08%-61K
-45.45%-64K
15.22%-39K
-17.78%-53K
-8.93%-183K
-14.29%-48K
-4.76%-44K
-9.52%-46K
Net common stock issuance
--0
-45.72%3.15M
-94.09%258K
342.66%2.23M
-21.45%443K
-40.91%221K
271.66%5.81M
109,075.00%4.37M
-25.66%504K
16.05%564K
Cash dividends paid
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Proceeds from stock option exercised by employees
----
109.07%4.24M
--0
----
----
----
-59.44%2.03M
--0
----
----
Net other financing activities
----
1.91%-820K
130.98%114K
-148.98%-854K
66.67%-25K
-10.00%-55K
6.07%-836K
47.58%-368K
-572.55%-343K
-20.97%-75K
Cash from discontinued financing activities
Financing cash flow
-162.14%-64K
-6.51%6.33M
-92.46%297K
160.87%5.57M
-15.47%366K
-61.57%103K
24.32%6.77M
-7.23%3.94M
273.08%2.13M
17.98%433K
Net cash flow
Beginning cash position
17.78%8.72M
-48.92%7.4M
76.39%9.59M
-27.41%4.74M
-42.19%5.77M
-48.92%7.4M
-3.60%14.49M
-64.00%5.44M
-62.07%6.52M
-54.37%9.99M
Current changes in cash
-94.07%-3.14M
118.48%1.31M
-144.52%-874K
547.38%4.87M
69.01%-1.07M
64.06%-1.62M
-1,090.59%-7.08M
396.53%1.96M
47.59%-1.09M
25.81%-3.46M
Effect of exchange rate changes
9.09%-10K
275.00%7K
---1K
-633.33%-16K
800.00%35K
-450.00%-11K
-107.41%-4K
--0
115.00%3K
78.26%-5K
End cash Position
-3.55%5.57M
17.78%8.72M
17.78%8.72M
76.39%9.59M
-27.41%4.74M
-42.19%5.77M
-48.92%7.4M
-48.92%7.4M
-64.00%5.44M
-62.07%6.52M
Free cash flow
-57.79%-3.12M
60.61%-5.66M
46.87%-1.07M
67.68%-1.07M
61.12%-1.55M
61.08%-1.98M
27.91%-14.37M
59.57%-2.01M
9.85%-3.3M
23.89%-3.98M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -57.79%-3.12M60.63%-5.66M47.02%-1.07M67.62%-1.07M61.17%-1.54M61.08%-1.98M27.89%-14.37M59.57%-2.01M9.87%-3.3M23.88%-3.98M
Net income from continuing operations 80.48%-89K-263.95%-26.49M-5,596.87%-23.64M-95.36%-1.31M54.91%-1.09M87.94%-456K63.56%-7.28M91.46%-415K86.79%-668K53.20%-2.42M
Depreciation and amortization 44.44%65K9.14%203K32.50%53K18.37%58K-4.08%47K-6.25%45K-5.58%186K-16.67%40K-2.00%49K-7.55%49K
Other non cash items -127.58%-2.16M74.07%-966K132.78%197K95.43%-67K85.03%-146K-38.69%-950K-62.42%-3.73M57.32%-601K-111.71%-1.47M-4,000.00%-975K
Change In working capital -44.79%-1.03M118.65%808K287.85%1.89M103.50%47K60.66%-415K23.66%-710K-1,681.02%-4.33M-195.08%-1M-184.36%-1.34M-66.40%-1.06M
-Change in payables and accrued expense -104.98%-947K114.79%655K242.42%1.6M98.38%-24K58.68%-457K35.56%-462K-1,816.28%-4.43M-202.19%-1.12M-218.17%-1.48M-30.89%-1.11M
-Change in other current assets 67.34%-81K59.38%153K144.07%288K-49.29%71K-17.65%42K-16.43%-248K-46.07%96K387.80%118K-58.46%140K-75.83%51K
Cash from discontinued investing activities
Operating cash flow -57.79%-3.12M60.63%-5.66M47.02%-1.07M67.62%-1.07M61.17%-1.54M61.08%-1.98M27.89%-14.37M59.57%-2.01M9.87%-3.3M23.88%-3.98M
Investing cash flow
Cash flow from continuing investing activities -80.93%49K24.17%632K-373.68%-104K416.67%372K22.99%107K-17.63%257K-96.33%509K-48.65%38K-92.84%72K-56.06%87K
Net PPE purchase and sale -------3K---9K--8K----------0--0--0--0
Net intangibles purchase and sale --------------------------0------------
Net business purchase and sale ------0------------------0--0--0--0
Net investment purchase and sale -99.10%2K137.57%449K---147K10,600.00%315K1,100.00%60K18.18%221K-98.87%189K--0-100.34%-3K66.67%5K
Net other investing changes ---4K------------------------------------
Cash from discontinued investing activities
Investing cash flow -82.49%45K24.17%632K-373.68%-104K416.67%372K22.99%107K-17.63%257K-96.33%509K-48.65%38K-92.84%72K-56.06%87K
Financing cash flow
Cash flow from continuing financing activities -162.14%-64K-6.51%6.33M-120.23%-797K212.14%6.66M-15.47%366K-61.57%103K24.32%6.77M-7.23%3.94M273.08%2.13M17.98%433K
Net issuance payments of debt -11.32%-59K-18.58%-217K-27.08%-61K-45.45%-64K15.22%-39K-17.78%-53K-8.93%-183K-14.29%-48K-4.76%-44K-9.52%-46K
Net common stock issuance --0-45.72%3.15M-94.09%258K342.66%2.23M-21.45%443K-40.91%221K271.66%5.81M109,075.00%4.37M-25.66%504K16.05%564K
Cash dividends paid --0--0--0--0--0--0--0--0--0--0
Proceeds from stock option exercised by employees ----109.07%4.24M--0-------------59.44%2.03M--0--------
Net other financing activities ----1.91%-820K130.98%114K-148.98%-854K66.67%-25K-10.00%-55K6.07%-836K47.58%-368K-572.55%-343K-20.97%-75K
Cash from discontinued financing activities
Financing cash flow -162.14%-64K-6.51%6.33M-92.46%297K160.87%5.57M-15.47%366K-61.57%103K24.32%6.77M-7.23%3.94M273.08%2.13M17.98%433K
Net cash flow
Beginning cash position 17.78%8.72M-48.92%7.4M76.39%9.59M-27.41%4.74M-42.19%5.77M-48.92%7.4M-3.60%14.49M-64.00%5.44M-62.07%6.52M-54.37%9.99M
Current changes in cash -94.07%-3.14M118.48%1.31M-144.52%-874K547.38%4.87M69.01%-1.07M64.06%-1.62M-1,090.59%-7.08M396.53%1.96M47.59%-1.09M25.81%-3.46M
Effect of exchange rate changes 9.09%-10K275.00%7K---1K-633.33%-16K800.00%35K-450.00%-11K-107.41%-4K--0115.00%3K78.26%-5K
End cash Position -3.55%5.57M17.78%8.72M17.78%8.72M76.39%9.59M-27.41%4.74M-42.19%5.77M-48.92%7.4M-48.92%7.4M-64.00%5.44M-62.07%6.52M
Free cash flow -57.79%-3.12M60.61%-5.66M46.87%-1.07M67.68%-1.07M61.12%-1.55M61.08%-1.98M27.91%-14.37M59.57%-2.01M9.85%-3.3M23.89%-3.98M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +11.05%
Sample Name
Sample Code
 +1.03%
Sample Name
Sample Code
 -2.29%
4
VanEck Oil Services ETF
OIH
-3.00%
5
ProShares Ultra Energy
DIG
-3.15%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.02%
Sample Name
Sample Code
 +9.96%
Sample Name
Sample Code
 +9.80%
4
Qifu Technology
QFIN
+5.99%
5
Futu Holdings Ltd
FUTU
+5.64%
View More
Middle East conflict spreads to the stock market! How should investors respond?
The U.S.-Iran negotiations have entered a critical window! According to Bloomberg, both sides are close to signing a memorandum of understan Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -